A Market-Leading Biomedical Software Company Lifebit Closes $60 Million in Series B  

by Kay Aloha Villamor in September 29th, 2021

Lifebit Biotech Ltd, a London, UK–based leading precision medicine software, raised a $60 million Series B funding round.

The round was led by the global investment firm Tiger Global Management. Existing investors Eurazeo, Pentech Ventures, and Beacon Capital also participated.

The Series B funding round will be used to further Lifebit’s global expansion, with a focus on customer success and accelerating the growth of its team, and will crucially enable Lifebit to double down on client success – fueling further support for existing partners, as well as those to come.

Company: Lifebit Biotech Ltd

Raised: $60.0M

Round: Series B

Funding Month: September 2021

Lead Investors: Tiger Global Management

Additional Investors: Eurazeo, Pentech Ventures, and Beacon Capital

Company Website: https://lifebit.ai/

Software Category: Enterprise data platforms

About the Company: Lifebit builds enterprise data platforms for use by organizations with complex and sensitive biomedical datasets. Lifebit's patented federated technology securely unlocks access to biomedical data. From providing Trusted Research Environments for national precision medicine programs to enabling pharmaceutical companies to discover new drug targets faster, Lifebit empowers customers to transform how they leverage sensitive biomedical data.

Source: https://lifebit.ai/blog/lifebit-raises-60m-to-democratise-biomedical-data/

Your cart